Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
Name
PNAS-2013-Tsukamoto-17023-8.pdf
Size
942.42 KB
Format
Adobe PDF
Checksum (MD5)
51de9719995069b1a70347273804dddd
Author(s)
Mani, D. R.
Tsukamoto, Kosuke
Zhang, Songwen
Krieger, Monty
Shi, Jianru
Haagensen, Darrow E.
Otsuka, Fumiyuki
Guan, Jian
Smith, Jonathan D.
Weng, Wei
Date Issued
September 2013
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences (U.S.)
Citation
Tsukamoto, K., D. R. Mani, J. Shi, S. Zhang, D. E. Haagensen, F. Otsuka, J. Guan, et al. “Identification of Apolipoprotein D as a Cardioprotective Gene Using a Mouse Model of Lethal Atherosclerotic Coronary Artery Disease.” Proceedings of the National Academy of Sciences 110, no. 42 (October 15, 2013): 17023–17028.
Version
Final published version
Abstract
Mice with homozygous null mutations in the HDL receptor (scavenger receptor class B, type I, or SR-BI) and apolipoprotein E (apoE) genes [SR-BI/apoE double KO (SR-BI[superscript −/−]/apoE[superscript −/−] or dKO) mice] spontaneously develop occlusive, atherosclerotic coronary artery disease (CAD) and die prematurely (50% mortality at 42 d of age). Using microarray mRNA expression profiling, we identified genes whose expression in the hearts of dKO mice changed substantially during disease progression [at 21 d of age (no CAD), 31 d of age (small myocardial infarctions), and 43 d of age (extensive myocardial infarctions) vs. CAD-free SR-BI[superscript +/−]/apoE[superscript −/−] controls]. Expression of most genes that increased >sixfold in dKO hearts at 43 d also increased after coronary artery ligation. We examined the influence and potential mechanism of action of apolipoprotein D (apoD) whose expression in dKO hearts increased 80-fold by 43 d. Analysis of ischemia/reperfusion-induced myocardial infarction in both apoD KO mice and wild-type mice with abnormally high plasma levels of apoD (adenovirus-mediated hepatic overexpression) established that apoD reduces myocardial infarction. There was a correlation of apoD’s ability to protect primary cultured rat cardiomyocytes from hypoxia/reoxygenation injury with its potent ability to inhibit oxidation in a standard antioxidation assay in vitro. We conclude that dKO mice represent a useful mouse model of CAD and apoD may be part of an intrinsic cardioprotective system, possibly as a consequence of its antioxidation activity.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.1315986110
